Skip to main content

Tweets

#JuneIssue | Relapsing polychondritis is challenging to diagnosis owing to overlapping symptoms with other conditions Learn more about the clinical features and differential diagnoses in this #Review https://t.co/iXl9rQ0ONS

NatRevRheumatol @NatRevRheumatol ( View Tweet )

1 year 8 months ago
Kaiser/California EHR study of #SLE pregnancies (2011-2020) - 657 pregnancies in 453 prs; The live birth rate = 74%, 23% w/ Spontaneous Ab, 2% ectopic/molar & <1% stillbirths. Variable outcomes by race & ethnicity, aPL status & nephritis history https://t.co/gvmYpTuFon https://t.co/9TeG8kfLmK
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
JAMA full read comprehensive review of 'Chronic Pruritus' affecting 22%, 1% of all out pt visits - Dx algorithm - Pathophys - Rx options - Alternative Rx https://t.co/4sd2HqUX9Y https://t.co/FoVHFnfEPa
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Do you have a rheumatology question or case for Dr. Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/qvVEUoNYi5 https://t.co/duw6jg5xpp
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Hypertension not associated with High NSAID Doses in AxSpA At the SPARTAN meeting, Dr.Meade-Aguilar reported that amongst axSpA patients receiving NSAIDs, there was no diff in the risk for hypertension when comparing those on high vs. low dose NSAIDs. https://t.co/UsRfobVHO7 https://t.co/fGj5yO53Yk
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Save the date! We are covering #EULAR24! We'll be sharing recaps, videos, and more. https://t.co/vEQUZGAuJe
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
2 large 48-wk phase 3 trials (Be HEARD I/II) of Bimekizumab vs PBO in moderate-to-severe hidradenitis suppurativa shows BKZ to be safe & significantly effective (48% vs 29% & 52% vs 32%) vs PBO. https://t.co/xPXUd9vHyE https://t.co/uESOGYhAdw
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
Most leaders value loyalty. Great leaders put a higher premium on integrity. Loyalty is allegiance to power. You're expected to show deference and follow orders. Integrity is allegiance to principles. You're expected to challenge orders that violate your mission or values.

Adam Grant @AdamMGrant ( View Tweet )

1 year 8 months ago
No Great Options for Treating VEXAS For patients with the auto-inflammatory disease VEXAS, treatment decisions are unfortunately fraught with tradeoffs between effectiveness and risk of adverse effects, a French registry study showed. https://t.co/tjCX1STnnD https://t.co/Bn40Nfxy9Y
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
The Window of Opportunity (5.24.2024) Dr. Jack Cush reviews the journal reports and news from the past week on https://t.co/V10S4oVFsv. This week: blockbuster drugs, opioids in rheumatology and nontreatment of inflammatory arthritis? https://t.co/zSjb2tKPWY

Dr. John Cush @RheumNow ( View Tweet )

1 year 8 months ago
Preliminary results of ph IIB ORIGIN trial of placebo vs Atacicept (binds BAFF & APRIL)in 166 pts w/ IgA Nephropathy (Berger’s Dz) Gd-IgA1, hematuria, and UPCR (vs PBO) in the blinded 1st 36 weeks of the trial. https://t.co/tPhCrSaSTC https://t.co/6HqGFtb1IE
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
NHANES study of 2500 #RA pts, found a significant correlation between an inflammatory diet (meas by DII score) and inflammatory indices like systemic immune-inflamm Index (SII) & neutrophil-lymphocyte ratio (NLR) https://t.co/sWXZRrG6hV https://t.co/9IcLDF1Jlo
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
×